Literature DB >> 11687971

A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.

M Glondu1, P Coopman, V Laurent-Matha, M Garcia, H Rochefort, E Liaudet-Coopman.   

Abstract

Cathepsin-D, a lysosomal aspartyl proteinase, is highly secreted by breast cancer cells and its over-expression by transfection stimulates cancer cell proliferation. The mechanism by which this protease affects proliferation remains, however, unknown. In order to determine whether proteolytic activity is necessary, we abolished its enzymatic activity using site-directed mutagenesis followed by stable transfection in 3Y1-Ad12 cancer cells. Substitution of the aspartic acid residue 231 by an asparagine residue in its catalytic site abrogated the cathepsin-D proteolytic activity but did not affect its expression level, processing or secretion. However, like wild-type cathepsin-D, this mutated catalytically-inactive cathepsin-D retained its capacity to stimulate proliferation of cells embedded in Matrigel or collagen I matrices, colony formation in soft agar and tumor growth in athymic nude mice. Addition on the mock-transfected cells, of either conditioned media containing the wild-type or the mutated pro-cathepsin-D, or of the purified mutated pro-cathepsin-D, partially mimicked the mitogenic activity of the transfected cathepsin-D, indicating a role of the secreted pro-enzyme. Moreover, addition of two anti-cathepsin-D antibodies on the cathepsin-D transfected cells inhibited their proliferation, suggesting an action of the secreted pro-cathepsin-D via an autocrine loop. A synthetic peptide containing the 27-44 residue moiety of the cathepsin-D pro-fragment was, however, not mitogenic suggesting that a receptor for the pro-fragment was not involved. Furthermore, the cathepsin-D mitogenicity was not blocked by inhibiting the interaction of pro-cathepsin-D with the mannose-6-phosphate receptors. Our results altogether demonstrate that a mutated cathepsin-D devoid of catalytic activity is still mitogenic and suggest that it is acting extra-cellularly by triggering directly or indirectly a yet unidentified cell surface receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687971     DOI: 10.1038/sj.onc.1204843

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

1.  Cathepsin D: Regulation in mammary gland remodeling, misregulation in breast cancer.

Authors:  Evette S Radisky
Journal:  Cancer Biol Ther       Date:  2010-09-30       Impact factor: 4.742

2.  Insulin-like growth factor II mediates resveratrol stimulatory effect on cathepsin D in breast cancer cells.

Authors:  Sharda Vyas; Yayesh Asmerom; Daisy D De León
Journal:  Growth Factors       Date:  2006-03       Impact factor: 2.511

3.  Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity.

Authors:  M Beaujouin; S Baghdiguian; M Glondu-Lassis; G Berchem; E Liaudet-Coopman
Journal:  Oncogene       Date:  2006-03-23       Impact factor: 9.867

4.  Microporation is a valuable transfection method for gene expression in human adipose tissue-derived stem cells.

Authors:  Yan-Hsiung Wang; Mei-Ling Ho; Je-Ken Chang; Hai-Chang Chu; Shu-Chin Lai; Gwo-Jaw Wang
Journal:  Mol Ther       Date:  2008-12-09       Impact factor: 11.454

5.  Many Roles of CCL20: Emphasis on Breast Cancer.

Authors:  Kingsley O Osuala; Bonnie F Sloane
Journal:  Postdoc J       Date:  2014-03

6.  CNS-expressed cathepsin D prevents lymphopenia in a murine model of congenital neuronal ceroid lipofuscinosis.

Authors:  Zinayida Shevtsova; Manuel Garrido; Jochen Weishaupt; Paul Saftig; Mathias Bähr; Fred Lühder; Sebastian Kügler
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

7.  Global analysis of protein folding thermodynamics for disease state characterization.

Authors:  Jagat Adhikari; Graham M West; Michael C Fitzgerald
Journal:  J Proteome Res       Date:  2015-04-09       Impact factor: 4.466

8.  Evaluation of serum cathepsin B and D in relation to clinicopathological staging of colorectal cancer.

Authors:  Elzbieta Skrzydlewska; Mariola Sulkowska; Andrzej Wincewicz; Mariusz Koda; Stanislaw Sulkowski
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

9.  Lowering Endogenous Cathepsin D Abundance Results in Reactive Oxygen Species Accumulation and Cell Senescence.

Authors:  Siyuan Su; Xu Zhu; Liang Lin; Xianwei Chen; Yang Wang; Jin Zi; Yusheng Dong; Yingying Xie; Yinghui Zhu; Ju Zhang; Jianhui Zhu; Dan Xu; Ningzhi Xu; Xiaomin Lou; Siqi Liu
Journal:  Mol Cell Proteomics       Date:  2015-12-10       Impact factor: 5.911

10.  Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo.

Authors:  Valerie Cullen; Maria Lindfors; Juliana Ng; Anders Paetau; Erika Swinton; Piotr Kolodziej; Heather Boston; Paul Saftig; John Woulfe; Mel B Feany; Liisa Myllykangas; Michael G Schlossmacher; Jaana Tyynelä
Journal:  Mol Brain       Date:  2009-02-09       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.